Biopharmaceutical company

A pioneer in the best cannabis plant genetics and extraction method, Grüne Labs yields medicinal cannabis to reach an effective broad-spectrum treatment.

Certificates

GACP

Good agricultural practices applied to the cultivation, harvesting, drying, packaging and collection of cannabis sativa inflorescences for medicinal use, in inflorescence and extract modality.

GMP

Good Manufacturing Practices for drying plant material and obtaining extracts based on cannabis (psychoactive and non-psychoactive) for use in the pharmaceutical industry.

Grüne Labs yields singular medicines to treat neurological diseases and other pathologies.

Analysis Certificated

Guaranteed and Analyzed by:

Welcome to Grune Labs

Leaders in cannabis production since 2016. Enabled by IRCCA under the cultivation license since 2018 and industrialization laboratory authorization granted by the MSP since 2020.

Our Services

We combine biotechnology and pharmaceuticals to achieve high quality products.

Cultivation

Laboratory

Cannabis has been used for therapeutic purposes for more than 4,000 years.

Uruguay

We investigate the development of botanical extracts for medicinal purposes with the support of the Technological Park of Pando, Uruguay.

Portugal

Located in the central area of ​​Portugal, GrüneLabs has geographical advantages as it is 248 km away from Lisbon, 268 km away from Porto and 386 km from Madrid, important entry gates to Europe.

 

Contact Us

Fill in your details. We’ll be in touch shortly.

GrüneLabs is a global biopharmaceutical company with operations in Uruguay, and Portugal.

+598 2291 4543

Parque Científico y Tecnológico de Pando
91000, Pando

Departamento de Canelones

Parque Industrial Gardunha Sul

Estrada Nacional 18, km 80,5

6005-300 | Soalheira

Castelo Branco